Home
  >  
Section 55
  >  
Chapter 54,555

Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study

Faerch, K.; Vaag, A.; Holst, J.J.; Hansen, T.; Jørgensen, T.; Borch-Johnsen, K.

Diabetes Care 32(3): 439-444

2009

ISSN/ISBN: 1935-5548
PMID: 19056613
DOI: 10.2337/dc08-1195
Accession: 054554654
Download citation:  
Text
  |  
BibTeX
  |  
RIS
The aim of this study was to describe the natural history of insulin secretion and insulin sensitivity in the development of isolated impaired fasting glycemia (i-IFG), isolated impaired glucose tolerance (i-IGT), and combined IFG/IGT. Baseline and 5-year follow-up data from the Inter99 study were used. Individuals with normal glucose tolerance (NGT) at baseline and i-IFG, i-IGT, combined IFG/IGT, or NGT at the 5-year follow-up were examined with an oral glucose tolerance test (n = 3,145). Insulin sensitivity index (ISI), homeostasis model assessment of insulin sensitivity (HOMA-IS), early-phase insulin release (EPIR), and insulin secretion relative to insulin action (disposition index) were estimated. Five years before the pre-diabetes diagnoses (i-IFG, i-IGT, and IFG/IGT), ISI, HOMA-IS, EPIR, and disposition index were lower than in individuals who maintained NGT. During the 5-year follow-up, individuals developing i-IFG experienced a significant decline only in HOMA-IS, whereas individuals developing i-IGT experienced significant declines in ISI, EPIR, and disposition index. Individuals with IFG/IGT exhibited pronounced declines in ISI, HOMA-IS, EPIR, and disposition index during the 5-year follow-up. A stationary reduced insulin secretion followed by a decline in primarily hepatic insulin sensitivity characterizes the transition from NGT to i-IFG. In contrast, low whole-body insulin sensitivity with a secondary lack of beta-cell compensation is associated with the development of i-IGT. Thereby, i-IFG and i-IGT appear to result from different underlying mechanisms, which may have implications for the prevention and treatment of the diabetes that succeeds them.

PDF emailed within 0-6 h: $19.90




Related References

Hanefeld, M.; Koehler, C.; Fuecker, K.; Henkel, E.; Schaper, F.; Temelkova-Kurktschiev, T. 2003: Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study Diabetes Care 26(3): 868-874
Dimitrijevic Sreckovic, V.; Djordevic, P.; Canovic, F.; Obrenovic, R.; Gostiljac, D. 2003: Evaluation of antioxidative activity, insulin sensitivity and insulin secretion in early glucoregulation disorders-impaired fasting glucose and impaired glucose tolerance Diabetes and Metabolism 29(Hors serie 2): 4S65
Tang, K.T.; Ho, L.T.; Jap, T.S.; Chang, T.C.; Ching, K.N.; Lam, H.C.; Wu, M.S.; Lee, S.P. 1990: Comparison of insulin secretion and insulin sensitivity between normal and impaired glucose tolerance subjects with normal fasting plasma glucose Zhonghua Yi Xue Za Zhi 46(2): 73-78
Masuda, K.; Aoki, K.; Terauchi, Y. 2011: Effects of miglitol taken just before or after breakfast on plasma glucose, serum insulin, glucagon and incretin levels after lunch in men with normal glucose tolerance, impaired fasting glucose or impaired glucose tolerance Journal of Diabetes Investigation 2(6): 435-440
Succurro, E.; Marini, M.A.; Riccio, A.; Fiorentino, T.V.; Perticone, M.; Sciacqua, A.; Andreozzi, F.; Sesti, G. 2022: Sex-differences in insulin sensitivity and insulin secretion in subjects with impaired fasting glucose and impaired glucose tolerance Diabetes Research and Clinical Practice 194: 110185
Liu, Y.; Li, J.; Wu, Y.; Zhang, H.; Lv, Q.; Zhang, Y.; Zheng, X.; Tong, N. 2022: Evidence from a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should be Divided into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined with Impaired Fasting Glucose, According to the Risk of Progression to Diabetes Frontiers in Endocrinology 13: 835460
Roy, A.; Kamalanathan, S.; Sahoo, J.; Kar, S.S.; Naik, D.; Narayanan, N.; Merugu, C.; Patel, D. 2021: Comparison of islet cell function, insulin sensitivity, and incretin axis between Asian-Indians with either impaired fasting glucose or impaired glucose tolerance, and normal healthy controls Diabetes Research and Clinical Practice 176: 108846
Laakso, M.; Zilinskaite, J.; Hansen, T.; Boesgaard, T.W.øv.; Vänttinen, M.; Stancáková, A.; Jansson, P.-A.; Pellmé, F.; Holst, J.J.; Kuulasmaa, T.; Hribal, M.L.; Sesti, G.; Stefan, N.; Fritsche, A.; Häring, H.; Pedersen, O.; Smith, U.; Smith, U.; Laakso, M.; Häring, H.; Sesti, G.; Pederson, O.; Zierath, J.; Joost, H.-G.; Beguinot, F.; Van Obberghen, E.; Auwerx, J.; Bosch, F.; Lind, P. 2008: Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study Diabetologia 51(3): 502-511
Bacha, F.; Gungor, N.; Lee, S.; Arslanian, S.A. 2009: In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes? Diabetes Care 32(1): 100-105
Moro, E.; Gallina, P.; Pianetti, S.; Pais, M.; Bon, G.B.ttolo 2001: Insulin secretion and insulin resistance in impaired fasting glucose and impaired glucose tolerance subjects Diabetologia 44(Suppl 1): A 56
Onishi, Y.; Hayashi, T.; Sato, K.K.; Leonetti, D.L.; Kahn, S.E.; Fujimoto, W.Y.; Boyko, E.J. 2018: Natural history of impaired glucose tolerance in Japanese Americans: Change in visceral adiposity is associated with remission from impaired glucose tolerance to normal glucose tolerance Diabetes Research and Clinical Practice 142: 303-311
Snehalatha, C.; Ramachandran, A.; Sivasankari, S.; Satyavani, K.; Vijay, V. 2003: Insulin secretion and action show differences in impaired fasting glucose and in impaired glucose tolerance in Asian Indians Diabetes/Metabolism Research and Reviews 19(4): 329-332
Wang, Y.; Ma, Y.-r.; Li, S.-l.; Ma, Y.-n.; Wu, L.; Zhao, L.-m.; Song, X.-x.; Ge, J.-p.; Xu, Y.-c. 2012: Secretion and action of insulin among Han and Uygur subjects with impaired fasting glucose and impaired glucose tolerance from Xinjiang Zhonghua Liu Xing Bing Xue Za Zhi 33(9): 961-963
Carnevale Schianca, G.P.; Rossi, A.; Sainaghi, P.P.; Maduli, E.; Bartoli, E. 2003: The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance Diabetes Care 26(5): 1333-1337
Heni, M.; Machann, J.ür.; Staiger, H.; Schwenzer, N.F.; Peter, A.; Schick, F.; Claussen, C.D.; Stefan, N.; Häring, H.-U.; Fritsche, A. 2010: Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study Diabetes/Metabolism Research and Reviews 26(3): 200-205
González-Ortiz, M.; Hernández-Salazar, E.; Kam-Ramos, A.él.M.; Martínez-Abundis, E. 2007: Effect of pioglitazone on insulin secretion in patients with both impaired fasting glucose and impaired glucose tolerance Diabetes Research and Clinical Practice 75(1): 115-118
Abdul-Ghani, M.A.; Jenkinson, C.P.; Richardson, D.K.; Tripathy, D.; DeFronzo, R.A. 2006: Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study Diabetes 55(5): 1430-1435
Miyazaki, Y.; Akasaka, H.; Ohnishi, H.; Saitoh, S.; DeFronzo, R.A.; Shimamoto, K. 2008: Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects Hypertension Research: Official Journal of the Japanese Society of Hypertension 31(7): 1357-1363
Theodorakis, M.J.; Muller, D.C.; Carlson, O.; Egan, J.M. 2003: Assessment of insulin sensitivity and secretion indices from oral glucose tolerance testing in subjects with fasting euglycemia but impaired 2-hour plasma glucose Metabolism, Clinical and Experimental 52(11): 1523-1524; Discussion 1524-1525
Katayama, H.; Tachibana, D.; Hamuro, A.; Misugi, T.; Motoyama, K.; Morioka, T.; Fukumoto, S.; Emoto, M.; Inaba, M.; Koyama, M. 2015: Sustained Decrease of Early-Phase Insulin Secretion in Japanese Women with Gestational Diabetes Mellitus who Developed Impaired Glucose Tolerance and Impaired Fasting Glucose Postpartum Japanese Clinical Medicine 6: 35-39